Podcast appearances and mentions of Fiona Godlee

Healthcare leadership advice from Sir Bruce Keogh, Dr Eric Topol, Dr Susan Thomas, Dr Fiona Godlee, Dr Ben Maruthappu, Dr Claire Novorol, Will Gibbs, Prof Pearse Keane, Prof Neil Sebire, Melissa Morris and Will Gibbs. All the greatest hits. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Ein Standpunkt von Peter Doshi, Fiona Godlee und Kamran Abbasi - aus dem Englischen ins Deutsche übersetzt von Bastian Barucker.Anmerkung Bastian Barucker: Am 19. Januar verfassten zwei aktuelle Chefredakteure und die ehemalige Chefredakteurin des British Medical Journal, einer der renommiertesten Medizinfachzeitschriften der Welt, ein Editorial zu den Covid-19-Impfstoffen. Dr. Peter Doshi, einer der Verfasser, hatte bereits am 2. November 2021 eine sehr aufschlussreiche Präsentation zur Covid-19-Impfung auf Einladung eines US-Senators gehalten. In dieser hatte er bereits zu mehr “kritischem Denken” aufgefordert und die Wirksamkeit der Impfung stark in Frage gestellt. Im aktuellen Aufruf fordern die 3 Redakteure die sofortige Herausgabe der Rohdaten zu allen Covid-19-Impfstoffen und erinnern vehement daran, dass die Regulierungsbehörden nicht die Pharmaindustrie, die aktuell Milliardengewinne macht, zu schützen hat, sondern die öffentliche Gesundheit. Außerdem wird in ihrem Schreiben deutlich wie intransparent die Zulassungsverfahren ablaufen und wie stark die Hersteller die Hauptverfasser der Zulassungsstudien sind. Ein sehr lesenswerter Brief.Die Daten sollten vollständig und unmittelbar für die Öffentlichkeit zugänglich sein.Vor zehn Jahren, mitten in einer anderen Pandemie, wurde in der Zeitschrift "The BMJ" (British Medical Journal) bekannt, dass Regierungen in aller Welt Milliarden für die Beschaffung von antiviralen Grippemitteln ausgegeben hatten, die nachweislich das Risiko von Komplikationen, Krankenhauseinweisungen oder Todesfällen nicht verringern. Die meisten Studien, die die Zulassung und die staatliche Beschaffung von Oseltamivir (Tamiflu) untermauerten, wurden vom Hersteller gesponsert; die meisten waren unveröffentlicht, die veröffentlichten wurden von Autoren verfasst, die vom Hersteller bezahlt wurden, die als Hauptautoren aufgeführten Personen hatten keinen Zugang zu den Rohdaten, und Wissenschaftlern, die für eine unabhängige Analyse Zugang zu den Daten beantragten, wurde der Zugang verweigert (1, 2, 3, 4).Die Tamiflu-Saga läutete ein Jahrzehnt ein, in dem die Bedeutung der gemeinsamen Nutzung von Daten aus klinischen Studien in nie dagewesenem Ausmaß betont wurde (5, 6). Öffentliche Kämpfe um Daten von Arzneimittelherstellern (7, 8), Transparenzkampagnen mit Tausenden von Unterschriften (9, 10), verschärfte Anforderungen an die gemeinsame Nutzung von Daten in Fachzeitschriften (11, 12), ausdrückliche Zusagen von Unternehmen zur gemeinsamen Nutzung von Daten (13), neue Internetportale für den Datenzugang (8) und wegweisende Transparenzrichtlinien von Arzneimittelbehörden (14, 15) – all dies versprach eine neue Ära der Datentransparenz.Es wurden zwar Fortschritte erzielt, aber eindeutig nicht genug. Die Fehler der letzten Pandemie werden nun wiederholt. Das Gedächtnis ist kurz. Trotz der weltweiten Einführung von Covid-19-Impfstoffen und -Behandlungen sind die anonymisierten Teilnehmerdaten, die den Studien für diese neuen Produkte zugrunde liegen, Ärzten, Forschern und der Öffentlichkeit nach wie vor nicht zugänglich – und das wird wahrscheinlich auch noch jahrelang so bleiben (16). Dies ist bei allen Studien moralisch nicht vertretbar, besonders aber bei solchen, bei denen es um wichtige Eingriffe in die öffentliche Gesundheit geht. ...hier weiterlesen: https://apolut.net/covid-19-impfstoffe-und-behandlungen-wir-brauchen-jetzt-die-rohdaten-von-peter-doshi-fiona-godlee-und-kamran-abbasi/ See acast.com/privacy for privacy and opt-out information.

Fiona Godlee is stepping down as Editor-in-Chief of The BMJ after 16 years in the position. She was the first female editor of the journal, and over her tenure has seen a lot of changes - both to the publication she's run, and to the wider world of medicine. To mark her departure, Helen Macdonald sat down with Fiona to ask her a bit about those early days at the journal, on her view of women taking leadership roles in medicine, on her thoughts about some of the big issues facing science, and what is coming next. Note from the editor; apologies for the audio quality in the first half.

In this podcast series, we will explore the many challenges facing the sustainability of healthcare and talk to extraordinary healthcare researchers, doctors, and activists from around the world, who are pushing for a shift towards a new paradigm to improve our health, well-being, and climate. We will talk about everything from an evolutionary patient revolt, challenging professional norms in medical practice, and the widespread use of low-value care in Low- and Middle-Income Countries, where the problem of waste is a great challenge to healthcare systems. These new emerging initiatives will be explored in our podcast episodes hosted by Ray Moynihan, journalist and researcher at Bond University, and Fiona Godlee, editor in chief, The BMJ

Climate change is a global health emergency. What can we learn from how ‘green' has gone up the agenda? And how might we apply useful lessons to getting further improvements in another complex and difficult challenge – improving the health of the UK population and reducing inequalities?    The increasing frequency and intensity of heatwaves, floods, droughts and storms is already devastating lives and livelihoods around the world. While other countries are far more vulnerable to the health risks of climate change, the UK is not immune.    The UK government and the health and social care system must actively contribute to climate change solutions as part of our global responsibility. In the weeks ahead the UK (along with Italy as a partner) will host COP26, and countries will be showing what action they are taking towards the Paris Agreement goal to limit global warming. Making progress on climate change will be very challenging. Like improving health, it is a complex problem needing long-term policy commitment and action. What can we learn from efforts and progress so far? And can going greener actually improve the health of people in the UK? In the latest episode of our podcast, our Chief Executive Dr Jennifer Dixon discusses these issues with two expert guests: Dr Fiona Godlee is Editor in Chief of the British Medical Journal, a post she's held since 2005. Fiona is on the board and executive committee of the Climate and Health Council and the UK Health Alliance on Climate Change.  Professor Andy Haines is Professor of Environmental Change and Public Health at the London School of Hygiene and Tropical Medicine. Andy is a member of several major international and national committees, including the UN Intergovernmental Panel on Climate Change. Useful links: The Health Foundation (2021) What do the public think about the NHS and climate change? UN Environment Programme (2021) The production gap 2021 Academy of Medical Sciences and the Royal Society (2021) Climate change and health HM Government (2021) Net Zero Strategy: Build Back Greener  HM Government (2020) The Ten Point Plan for a Green Industrial Revolution Council for Science and Technology (2020): Achieving net zero carbon emissions through a whole systems approach

Dr Will Liddell and  Dr Fiona Godlee, Editor in Chief of the British Medical Journal, discuss the threats to public health posed by environmental change and the role of medical journals in alerting doctors to the challenges we face in confronting climate change. We also discuss the role of the BMJ in campaigning for greater transparency in clinical research and issues of gender and race in medicine.  Sound engineering by Rob Wynne-Griffiths.  

What's the biggest existential threat to the BMJ? Dr Fiona Godlee is the Editor-in-Chief of the British Medical Journal and is an Executive Director of the BMJ Company. She trained as a General Physician in Cambridge and London, before joining the BMJ as an Editorial Registrar. Dr Godlee is incredibly interesting and forthcoming with the realities of running a medical journal — we talk about how the BMJ is not just a medical journal but a societal intervention, existential threats to the BMJ, the future vision and what Dr Godlee's learned about leadership on her journey. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Many surgeries have been cancelled during the pandemic, with good reason, as early data showed the increase in mortality associated with a coronavirus infection, but now waiting lists grow, and there are questions about how the NHS will pick up the slack. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to the full panel; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton. They are joined by Mary Venn, research fellow, and honorary surgical registrar in London, who's been looking into the pandemic's effect on surgery. For more on that research: http://nihrglobalsurgery.org/surgeryduringcovid To register for our covid known unknowns webinar - https://www.bmj.com/covid-19-webinars

In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton. This week our special guest is Rachel Clarke, author and palliative care specialist. The panel discuss how end of life care has changed in the pandemic, and how clinicians have become targets of abuse on social media, for speaking out about things like masks and hospital capacity.

The "public health emergency of international concern" was issued by the WHO a year and a lifetime ago. As the UK ramps up testing for the South African virus variant, and is full steam ahead on vaccination, we look back at what we've learned in that time. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They talk about working in the NHS at the moment, the utility of international comparisons, and their remaining questions about vaccination regimes. www.bmj.com/coronavirus

Recorded on the 26th January 2021 The UK has become, officially, the worst performing country in terms of Covid-19 deaths, per head of population - and the number of people in hospital is still higher than at any point in the pandemic. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They talk about working in the NHS at the moment, and the challenges in things like oxygen and vaccine supplies. How the pandemic has exposed a gap in general medicine, and the importance of challenging poor responses at all levels.

In the UK, over 37,000 people are in hospital with covid-19, and the NHS comes closer than ever to being overwhelmed - though 4 million people have received their first dose of the vaccine, we are warned that things will get worse before they get better. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to; Partha Kar, consultant in diabetes and endocrinology in Portsmouth, Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on hospitals, why GPs are questioning the need for max vaccination centres, and why the public health approach can't be just lockdown and vaccinations. www.bmj.com/coronavirus

Recorded Tuesday 5th Jan 2021 As the UK enters lockdown, again, schools are closed, the NHS struggles under the surge of cases, new variants of SARS-COV-2 virus stalk the world, and vaccination programmes make a faltering start. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, public health consultant in Southampton, about the pressure on critical care, England's vaccination roll out, the closure of schools and why communication is undermining trust in the vaccines. All the BMJ's corona virus coverage is currently free to access www.bmj.com/coronavirus

As London and some neighbouring counties move up to tier 3, and Germany, Italy and The Netherlands impose tighter restrictions over over the coming days of Christmas, in this podcast we ask - should Christmas gatherings be cancelled? In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They're joined by Mike Tildesley, reader in mathematics at Warwick School of Life Sciences, who models infectious disease spread. They discuss why the key to controlling is pruning network connections - but why that concept hasn't been well explained to the public, what's happening in Cardiff, where ICU is running at 120% capacity, and how the vaccine roll out is being coordinated in primary care. For more on the pandemic www.bmj.com/coronavirus

As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire. They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the non-vaccine ways of preventing spread need to be tightened up, especially now. For more of The BMJ's covid-19 coverage. www.bmj.com/coronavirus

As the first vaccine for corona virus is approved, and England joins the other nations of the UK outside of full lockdown, we are all entering tiers of restrictions - variable across the country, which will continue until that vaccine coverage is enough to slow transmission in the community. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and are re-joined by Karl Friston, neurologist and member of iSAGE. They discuss what we know about the efficacy of these tiers, and how they interact with things like track and trace, and the mass testing taking place in Liverpool. For more of The BMJ's covid-19 coverage. www.bmj.com/coronavirus

As further promising news emerges of vaccine effectiveness, although still with no data published, and as plans emerge for the return home of university students and limited festive winter celebrations. But as we talked about in the last podcast, there needs to be a concerted effort to re-centre patients and the public within the decisions made about how the NHS will treat covid patients and those with continuing healthcare conditions impacted by the pandemic. National Voices, a coalition of charities that stands for patient centred care, have been talking to patients about what matters to people during COVID-19 and beyond, and have written a report with some clear recommendations to health and care leaders and professionals. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton. They are joined by Charlotte Augst, Chief Executive of national voices to talk about that report; why some patients have felt abandoned; how covid has accelerated the conversation about rationing; and why now is the time to rebuild services around patient needs. www.bmj.com/coronavirus

Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton. They are joined by Katrina Pollock, senior clinical research fellow in vaccinology at Imperial College London, to talk about: the three vaccines in the news; why different groups may require different vaccines; and how to choose who to get the vaccination first. www.bmj.com/coronavirus

Dr Fiona Godlee, Editor-in-Chief of The British Medical Journal, joins for a fascinating discussion of the world of medical publishing and what can be done to improve future medical research. We cover conflict of interests, open data, investigative journalism, the future of the BMJ, health campaigning and medical journals’ own priorities to balance whilst at the forefront of scientific advancement.

Covid-19 continues its grip on the Northern Hemisphere alongside news of a vaccine trial showing real success at first glance. In this second wave update, we explore the latest issues with healthcare professionals from primary care, secondary care, and public health, and discuss what is happening in their field, and put their questions to experts. In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Alison Pittard, a consultant in anaesthesia and intensive care medicine in Leeds, and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton. They are joined by Müge Çevik, an infectious diseases researcher at the University of St Andrews, to talk about: what's happening with track and trace and how to make it work better; transmission and asymptomatic spread, in particular hospital-acquired infections; views on the news of Pfizer's vaccine; and reaction to US presidential election. www.bmj.com/coronavirus

As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS. In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts. In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire, and Nisreen Alwan, associate professor in public health at the University of Southampton. They are joined by Andrew Hayward, professor of infectious disease epidemiology and inclusion health research, to talk about the lockdown in England, why the message should be clearer, what needs to be done to make the lockdown work, and how doctors are braced for the upcoming surge in cases. https://www.bmj.com/coronavirus

As the second spike in covid-19 cases grows, we want to take stock of what's happening in the NHS. In these second wave updates, clinicians from primary care, secondary care, and public health, discuss what is happening in their field, and put questions to experts. In this podcast, Fiona Godlee, editor in chief of The BMJ talks to Matt Morgan, consultant in intensive care medicine in Cardiff and Helen Salisbury, GP in Oxfordshire - they discuss how full hospitals are getting, how many covid-19 cases are presenting in primary care, and how treating patients has fared as the pandemic hots up. For more on covid-19 visit https://www.bmj.com/coronavirus

This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans. We're still working on acknowledging some of the best medicine from around the UK, but in the meantime we've decided to give out the awards for outstanding contribution to health, and research paper of the year. In the following interview, Fiona Godlee - the BMJ's editor in chief, talks to Marian Knight, lead author of the ANODE trial - The BMJ's research paper of the year. For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/

This time of year we would usually be doing some podcasts from the BMJ awards - but the pandemic has delayed our plans. We're still working on acknowledging some of the best medicine from around the UK, but in the meantime we've decided to give out the awards for outstanding contribution to health, and research paper of the year. In the following interview, Fiona Godlee - the BMJ's editor in chief, talks to David Pencheon, director of the NHS sustainability unit about his work. For more about The BMJ Awards categories and previous winners; https://thebmjawards.bmj.com/

This week, we're asking questions about surgisphere data, and how it might have got into such high impact journals, we're also talking about the protests around the world about structural racism - and how they intersect with the covid pandemic. (1.39) Helen and Carl talk about the data underlying the newly retracted papers on hydroxychloroquine and ace-inhibitors or ARBs and covid. (7.45) Fiona Godlee, the BMJ's editor in chief, comes onto the pod to talk about retractions, and why they're often called for, an rarely done. (25.10) We talk about the protests, and Carl gives us his opinion on the risk of covid transmission during them (spoiler; he thinks it's low) (37.40) Sonia Saxena, professor of primary care at Imperial College London gives her verdict on the Public Health England report into this disproportionate effect of covid on ethnic minorities in the UK, and pushes back against it being a biological instead of a sociological determination. Reading list: Sonia's analysis into transforming the health system for the UK's multiethnic population https://www.bmj.com/content/368/bmj.m268  News Analysis - Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ https://www.bmj.com/content/369/bmj.m2264 The PHE report into the disparate risk of covid to ethnic minorities https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes

This week, we're asking questions about surgisphere data, and how it might have got into such high impact journals, we're also talking about the protests around the world about structural racism - and how they intersect with the covid pandemic. (1.39) Helen and Carl talk about the data underlying the newly retracted papers on hydroxychloroquine and ace-inhibitors or ARBs and covid. (7.45) Fiona Godlee, the BMJ's editor in chief, comes onto the pod to talk about retractions, and why they're often called for, an rarely done. (25.10) We talk about the protests, and Carl gives us his opinion on the risk of covid transmission during them (spoiler; he thinks it's low) (37.40) Sonia Saxena, professor of primary care at Imperial College London gives her verdict on the Public Health England report into this disproportionate effect of covid on ethnic minorities in the UK, and pushes back against it being a biological instead of a sociological determination. Reading list: Sonia's analysis into transforming the health system for the UK's multiethnic population https://www.bmj.com/content/368/bmj.m268  News Analysis - Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ https://www.bmj.com/content/369/bmj.m2264 The PHE report into the disparate risk of covid to ethnic minorities https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes

Dr Fiona Godlee is editor of The BMJ (formerly the British Medical Journal), one of the world’s most respected news outlets for clinicians, with a monthly print circulation of almost 125,000 and an online reach of nearly three million. Graduating in medicine from Cambridge and initially training in general practice, she then moved into research. She is also a Fellow of the Royal College of Physicians. Fiona started writing for the BMJ in 1990 on a range of topics including public health, and has been editor-in-chief since 2005. In this in-depth interview, she argues that the COVID-19 pandemic is even more serious than recognised, refutes the “guided by the science” defence and puts the government’s response down to political judgement and scarcity of resources, and blames the lack of “openness and […] courage” in communicating the true gravity of the health crisis, warning that a second wave is “sadly inevitable”.

This week, the Sharp Scratch team is joined by Dr Fiona Godlee, Editor in Chief of The BMJ to talk about what it's like to leave clinical medicine, and how it can be challenging to lose your medical identity. Our expert guests Fi Godlee is the first ever female Editor in Chief of The BMJ. Mayank Bhandari left medicine at the end of his foundation training to pursue a career in management consultancy.

Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University's CEBM and editor of BMJ Evidence) This month: (2.00) Helen look back at a Christmas article, which investigates a very common superstition in hospitals. (7.55) Carl has his pick of the top 100 altimetric most influential papers of the year. (12.40) We find out all about the preventing overdiagnosis conference which happened earlier in December. (34.15) Helen has her annual rant about misogeny in medicine. Reading list: Q fever—the superstition of avoiding the word “quiet” as a coping mechanism https://www.bmj.com/content/367/bmj.l6446 Altimetric Top 100 https://www.altmetric.com/top100/2019/ Fiona Godlee's keynote at Preventing Overdiagnosis https://www.preventingoverdiagnosis.net/ Gender differences in how scientists present the importance of their research: observational study https://www.bmj.com/content/367/bmj.l6573

Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University's CEBM and editor of BMJ Evidence) This month: (2.00) Helen look back at a Christmas article, which investigates a very common superstition in hospitals. (7.55) Carl has his pick of the top 100 altimetric most influential papers of the year. (12.40) We find out all about the preventing overdiagnosis conference which happened earlier in December. (34.15) Helen has her annual rant about misogeny in medicine. Reading list: Q fever—the superstition of avoiding the word “quiet” as a coping mechanism https://www.bmj.com/content/367/bmj.l6446 Altimetric Top 100 https://www.altmetric.com/top100/2019/ Fiona Godlee's keynote at Preventing Overdiagnosis https://www.preventingoverdiagnosis.net/ Gender differences in how scientists present the importance of their research: observational study https://www.bmj.com/content/367/bmj.l6573

Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King's College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King’s College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

The Food Programme invites a panel of four to discuss the merits of a low versus high carbohydrate diet. Following up on the issues raised in discussing the government's dietary advice in the Eatwell Guide a panel including Duane Mellor of the University of Coventry, Fiona Godlee of the British Medical Journal, Dr Trudi Deakin and Anthony Warner aka the Angry Chef try to answer some of the questions and bust some of the myths about carbohydrates. Producer: Maggie Ayre

The concept of overdiagnosis is pretty hard to get - especially if you've been educated in a paradigm where medicine has the answers, and it's only every a positive intervention in someone's life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you. You'll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute. The

Trial MVA85A - monkey trials for a booster vaccine for BCG, developed by researchers at Oxford University, is the subject of an investigation published on bmj.com. Experts warn that today's investigation is just one example of “a systematic failure” afflicting preclinical research and call for urgent action “to make animal research more fit for purpose as a valuable and reliable forerunner to clinical research in humans.” The press conference is led by Dr Fiona Godlee, the editor-in-chief of the BMJ, who provides a background to the investigation. The panel members are: Dr Deborah Cohen, author of the investigation and associate editor at the BMJ, talking about carrying out the investigation and the difficulty to obtain basic information Professor Paul Garner from the Liverpool School of Tropical Medicine, addressing the ineffectiveness of the current TB vaccine and also talking about the backlash he experienced after publishing a systematic review concluding that the animal studies results had been overstated Malcolm Macleod, from the University of Edinburgh, talking about the broader public health aspect Merel Ritskes-Hoitinga from the Department for Health Evidence in The Netherlands, addressing the quality of animal studies and the need for systematic reviews and Jonathan Kimmelman, from McGill University in Canada analysing the story from the perspective of biomedical ethics.

Investigative journalist Nina Teicholz joined Ken and Dawn remotely from a studio in New York City in mid-September for a fascinating discussion about the history and pitfalls of nutrition science. Teicholz is the author of the international bestseller, “The Big Fat Surprise: Why Butter, Meat & Cheese Belong in a Healthy Diet.” The Economist named it the number one science book of 2014 and the Journal of Clinical Nutrition wrote, “This book should be read by every scientist and every nutritional science professional.” Nina began her journalism career as a reporter for National Public Radio. She went on to write for many publications, including the Wall Street Journal, New York Times, Washington Post, The New Yorker, and The Economist. She attended Yale University and Stanford University where she studied biology and majored in American Studies. She has a master’s degree from Oxford University and served as associate director of the Center for Globalization and Sustainable Development at Columbia University. “The Big Fat Surprise” is credited with upending the conventional wisdom on dietary fat. It challenged the very core of America’s nutrition policy by explaining the politics, personalities, and history of how we came to believe that dietary fat is bad for health.  Her book was the first mainstream publication to make the full argument for why saturated fats – the kind found in dairy, meat and eggs – belong in a healthy diet. The Wall Street Journal, Forbes, Mother Jones, the Library Journal and Kirkus Review named “The Big Fat Surprise” one of the best books of 2014. The Economist described Nina’s book as a “nutrition thriller.” Links: -- Nina Teicholz blog -- Amazon: “Big Fat Surprise” http://amzn.to/2iQemXc -- BMJ: “The scientific report guiding the US dietary guidelines: is it scientific?” -- “A Review of the Dietary Guidelines by the National Academy of Medicine” -- STEM-Talk with Gary Taubes -- “Statistical Review of US Macronutrient Consumption date, 1965-2011” -- “What if Bad Fat is Actually Good for You?” Show notes: 4:10: Interview begins with Nina talking about how her father, an engineer who also enjoyed computer science, sparked her interest in science. 5:41: Dawn asks Nina if she would share the story about her failed fruit-fly experiment in high school. 8:07: Nina talks about how an assignment to do a story on trans fats led her to become friends with journalist Gary Taubes, the author of “Good Calories, Bad Calories,” whom Dawn and Ken interviewed on episode 37 of STEM-Talk. 11:40: Dawn talks about an article Nina wrote for Men’s Health Magazine titled, “What If Bad Fat Is Actually Good for You?” It’s the article where Nina first laid out her case that saturated fats may not be bad for people’s health and might actually be good for people. Dawn asks Nina if she got pushback on that article. 14:07: Dawn asks about a paper Nina published in BMJ titled, “The Scientific Report Guiding the US Dietary Guidelines: Is It Scientific?”  Dawn asks Nina to describe what happened when 180 scientists wrote a letter asking BMJ to retract the paper. 19:52: Dawn comments about how the pushback to the article seemed to violate the very process that science is supposed to follow. 21:30: Ken comments about the orchestrated effort to make Nina look bad, which leads Nina to highlight the support she received from BMJ and its editor Fiona Godlee. 22:55: Nina talks about the difficulty a journalist faces when challenging the work of scientists from institutions like Harvard and Yale. 24:16: Ken mentions how we’re seeing more and more dogma dressed up as science, which that leads to a discussion between Ken, Dawn and Nina about the shortcomings of nutrition science. 30:32: Dawn comments that Nina has been quoted as saying that institutionalized science is an oxymoron, and once institutions started adopting the principle that saturated fat caused heart disease,...

Who better to kick off a series on all things health and evidence than the exceptional and erudite Editor-in-Chief of The BMJ, Dr Fiona Godlee. In this episode, Fiona chats to Ray about the BMJ's ongoing and often controversial campaigns to change medicine - and broader society - for the better. She also looks to a future that addresses the distorting influence of industry funding on health evidence and outcomes, and let's us in on what drives and inspires her to achieve so much in her influential role at the helm of one of the world's oldest, most popular and prestigious journals. For a full transcript of this episode visit: https://australia.cochrane.org/trd-fiona-godlee-interview-transcript

"Too many research studies are poorly designed or executed. Too much of the resulting research evidence is withheld or disseminated piecemeal. As the volume of clinical research activity has grown the quality of evidence has often worsened, which has compromised the ability of all health professionals to provide affordable, effective, high value care for patients.” Evidence is in crisis, and Carl Heneghan, director for the Centre for Evidence Based Medicine, and Fiona Godlee, editor in chief of The BMJ set out the 9 points of the Evidence manifesto, which tries to set a road map for strengthening the evidence base. 1) Expand the role of patients, health professionals and policy makers in research 2) Increase the systematic use of existing evidence 3) Make research evidence relevant, replicable and accessible to end users. 4) Reduce questionable research practices, bias, and conflicts of interests 5) Ensure drug and device regulation is robust, transparent and independent 6) Produce better usable clinical guidelines. 7) Support innovation, quality improvement, and safety through the better use of real world data. 8) Educate professionals, policy makers and the public in evidence-based healthcare to make informed choices. 9) Encourage the next generation of leaders in evidence-based medicine. http://www.bmj.com/content/357/bmj.j2973

Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, in conversation with Dr Fiona Godlee, Editor-in-Chief of The British Medical Journal (BMJ). Trust the Evidence is a new podcast series presenting conversations with individuals interested in improving healthcare through the use of better evidence.

Transient symptoms of depersonalisation and derealisation - feeling detached from the world, and feeling as if you are watching events at a remove - are common. However for some, persistent symptoms can make the disorder extremely distressing. In this podcast, Kate Adlington is joined by Elaine Hunter, consultant clinical psychologist, Anthony David, professor of cognitive neuropsychiatry, and by Jane Charlton and Fiona Godlee - who have both experienced depersonalisation/derealisation over a number of years. Read the full education article: http://www.bmj.com/content/356/bmj.j745

Dr Mark Porter unpicks the science behind the so called 'weekend effect'. Politicians have quoted research claiming that people are 20% more likely to die of a stroke at the weekend, while another much cited study finds 11,000 more deaths in people admitted at the weekend. But how valid are these figures and the research that generated them? Dr Margaret McCartney reviews the stroke data that has been criticised by experts as being out of date. While Mark Porter talks to Editor of the BMJ, Fiona Godlee, who published the 11,000 figure but is concerned about the political use of the findings. And discusses the study with lead author Nick Freemantle, plus Consultant Surgeon Sam Nashef who is sceptical about the results.

Bias and peer review are of universal importance to all those that produce scholarly work. Fiona Godlee and Rob Tarr, editors in chief of The BMJ and JNIS respectively, share their insights and experience on these highly topical issues with Joshua Hirsch. Read the related paper: http://jnis.bmj.com/content/early/2015/04/17/neurintsurg-2015-011781.full

Bias and peer review are of universal importance to all those that produce scholarly work. Fiona Godlee and Rob Tarr, editors in chief of The BMJ and JNIS respectively, share their insights and experience on these highly topical issues with Joshua Hirsch. Read the related paper: http://jnis.bmj.com/content/early/2015/04/17/neurintsurg-2015-011781.full

The future of health and social care looks certain to be a defining issue in the forthcoming UK general election. Social care has been subject to deep public spending cuts, raising concerns about the sustainability of services in the future. Whoever wins the next election will need to grapple with providing joined up health and social care services in an era of continued austerity. A recent debate (heathdebate.net) with key spokespeople from across the political spectrum took place this week, and we assembled a panel of experts to discuss how they think the debate went, and the key promises and gaps in the parties plans for the NHS. Taking part were: Fiona Godlee, editor in chief of The BMJ Jeremy Taylor - chief executive of National Voices Johnny Marshall - director of policy at the NHS Confederation Jane Dacre - president of the Royal College of Physicians Anita Charlesworth - chief economist at the Health Foundation Mark Porter - chair of council at the BMA Nigel Edwards - chief executive of the Nuffield Trust Chris Ham - chief executive of The King's Fund For more analysis of the election's health promises, read Gareth Iacobucci's Election Watch column: http://www.bmj.com/content/350/bmj.h2165

The BMJ held a breakfast roundtable at the annual health policy summit held by the Nuffield Trust think tank to explore some of the key policy discussions that took place during the ​proceeding day. These included NHS England chief executive Simon Stevens' five year plan, whether politics can be removed from the NHS, and what the creation of a central unit to coordinate care for Manchester means for the rest of the ​NHS in England. Chaired by Fiona Godlee, editor in chief of The BMJ, the particpants were: Richard Jones - Clinical director of the Wessex Cardiovascular Strategic Clinical Network Suzie Bailey - Development director at health service regulator Monitor Jonathan Michael​ - ​chief executive of Oxford University Hospital NHS Trust Steve Field - Chief inspector of general practice for the Care Quality Commission Nigel Edwards - Chief executive of The Nuffield Trust Jeremy Taylor - Chief executive of health and care charity National Voices Massoud Fouladi - Chief medical officer of Circle Partnership Rebecca Rosen - GP and clinical commissioner of Greenwich Clinical Commissioning Group, London Jennifer Dixon - Chief executive of the Health Foundation

Participants in our discussion on person centred care in January agreed that a change in culture and better use of technology could benefit both patients and doctors. At the roundtable: Fiona Godlee (chair), editor in chief, The BMJ Tessa Richards, senior editor, patient partnership, The BMJ Rosamund Snow, patient editor, The BMJ Navjoyt Ladher, clinical editor, The BMJ Angela Coulter, director of global initiatives, Informed Medical Decisions Foundation (www.informedmedicaldecisions.org) Paul Wicks, vice president of innovation, PatientsLikeMe (www.patientslikeme.com) Michael Seres, founder, 11 Health (www.11health.com) Alf Collins, clinical associate in person centred care, Health Foundation (www.health.org.uk) Jeremy Taylor, chief executive, National Voices (www.nationalvoices.org.uk) Dave deBronkart, cochair, Society for Participatory Medicine (www.participatorymedicine.org) Amir Hannan, general practitioner and member of clinical commissioning group board Alexander Silverstein, past president, International Diabetes Federation's young leaders in diabetes project Paul Hodgkin, founder, Patient Opinion (www.patientopinion.org.uk) Ben Mearns, consultant in acute care and elderly medicine, Surrey and Sussex Healthcare NHS Trust Sara Riggare, PhD student in health informatics, Karolinska Institute Rupert Whitaker, founder, Tuke Institute (www.tukeinstitute.org) Stephen Leyshon (observer), DNV Healthcare

Royal Society investigates the decline in their awards to female scientists Last week, the UK's national science academy, the Royal Society, announced its latest round of University Research Fellows (URFs). And they are almost all fellows - in the male sense of the word. Out of 43 new posts, only two of them are women. These positions are for early-career, post-doctoral researchers. But, at the top of the tree, fewer than one in ten science professors are women, and one of the top UK scientific accolades - a Royal Society Fellowship - is held by only one in twenty. To their credit, The Royal Society were "horrified" by this latest round, and their president, Sir Paul Nurse, immediately called for a full investigation into how this happened, saying "this sends out a bad message to young female scientists". Our reporter Tracey Logan asks why Royal Society grants are so important to young scientists, and whether this year's number of female recipients is a sign of gender bias on the awarding committees, or just a statistical blip in a fair process? And Adam Rutherford meets Professor Julia Higgins to hear the latest just after participating in a diversity working group meeting at the Royal Society in London. Getting science out from behind paywalls You pay for science research via your taxes, but you may not get to see the results unless you pay again to read the journals that publish them. With two major UK science publishers, the Royal Society publishing and Nature, announcing one apiece of their journals are going fully open access -broadly, free for anyone to read online - we're discussing the way science makes it from the lab to the public, via the ever controversial system of publishing and peer review. Adam is joined by Fiona Godlee, Editor of the British Medical Journal; Lesley Anson, Chief Editor of Nature Communications; and Chris Lintott, Professor of Astrophysics and Citizen Science Lead at the University of Oxford. Producer: Fiona Roberts Assistant Producer: Jen Whyntie.

The BMJ, BMJ Open, Heart, Thorax, and Tobacco control – all journals in BMJ's stable, have announced they will no longer carry research funded in part, or in whole, by the tobacco industry. Fiona Godlee, BMJ Editor in chief, explains what that means, and Allen Brandt, professor of the history of science at Harvard University, gives us a potted history of the way in which the tobacco industry has manipulated science. Also this week, Sebastian Brandner, professor of neuropathology at UCL, explains his research into the population prevalence of the prion which causes vCJD. See also Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic http://www.bmj.com/content/347/bmj.f5675 Journal policy on research funded by the tobacco industry http://www.bmj.com/content/347/bmj.f5193

In this week's podcast we examine the link between toothbrushing and cardiovascular disease – Richard Watts talks about his research in Scotland. Also this week the Department of Health issued a statement that has made some people wonder about the future of NICE. Fiona Godlee discusses the statement with health economist James Raftery. Finally this week, Evan Harris may have recently lost his seat in parliament, but one thing that'll keep him busy is his new job as a columnist for the BMJ. Trevor Jackson talks to him about his first column on Wakefield and MMR.

This week we're joined by Jack Wennberg, author of the Dartmoth Atlas of Healthcare. He and Fiona Godlee discuss his work, and what the UK can learn from the US. Also this week what do you buy a MAMIL (Middle Aged Man in Lycra) for Christmas?

At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health The participants were: Fiona Godlee , editor in chief, BMJ Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 Marion Collict, national programme manager, shared decision making, NHS (UK's National Health System) Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health Margaret McCartney , writer and GP Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. Steve Woloshin , professor of medicine, Dartmouth Medical School “e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine Tessa Richards , analysis editor, BMJ Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford

At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health The participants were: Fiona Godlee , editor in chief, BMJ Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020 Marion Collict, national programme manager, shared decision making, NHS (UK's National Health System) Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health Margaret McCartney , writer and GP Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online. Steve Woloshin , professor of medicine, Dartmouth Medical School “e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine Tessa Richards , analysis editor, BMJ Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford

With the future of the Health and Social Care bill more certain, how will the health service react to the legislative changes? At this year's Nuffield Trust Health Policy Summit, the BMJ's editor Fiona Godlee hosted a round table to discuss this question. Taking part were: David Bennett, Chairman and CEO, Monitor Paul Corrigan, Management consultant, Southside Penny Dash, McKinseys Nigel Edwards, Kings Fund Clare Gerada, RCGP Gareth Goodier, CEO, Cambridge University Hospitals NHS Foundation Trust, Cambridge Alastair McLellan, Editor, Health Services Journal James Morrow, GP, Sawston, Cambridge Judith Smith, Nuffield Trust Simon Stevens, CEO, Global Health, United Health Group, USA Helen Thomas, Medical Director, Sentinel Commissioning, Plymouth For more from the summit, and to watch some of the keynote speeches, go to the Nuffield Trust site.

For the last year a group commissioned by the UK government has been looking at whether making all published research freely available is attainable or not. BMJ editor Fiona Godlee speaks to Dame Janet Finch, the group's chair, about its conclusions. We also bring you highlights from a BMJ hosted round table on what the landscape of research publishing could, and should, look like in the future.

Many patients are following a wheat free diet, which they believe helps with their gastrointestinal symptoms, yet they don't exhibit markers of coeliac disease. Mabel Chew finds out from David Sanders, a professor of gastroenterology at the Royal Hallamshire Hospital, about non-coeliac gluten sensitivity. Also, Fiona Godlee gives us an update on the open data campaign.

The issues of hidden data are well known, and the BMJ's open data campaign page documents some of the problems which have arisen as a result of clinical trial data remaining undisclosed. At Evidence Live 2013 in Oxford this week, Fiona Godlee, BMJ editor in chief, convened a group of those closely involved with the AllTrials campaign, to discuss where we are now and what still needs to be done

The BMJ Awards were held last Thursday. Fiona Godlee, the BMJ's editor in chief, announced that the Britain Nepal Otology Service (BRINOS) was named Medical Team of the Year. BRINOS (brinos.org.uk) started out in 1988 by setting up joint British and Nepalese surgical camps to treat ear disease among patients living outside the reach of hospitals in the capital of Kathmandu. A national survey in 1991 found that among the 19m people in Nepal, 2.7m were deaf and 1.5m had abnormal ear drums indicative of ear disease. BRINOS has performed more than 4000 major ear operations at 49 surgical day camps since its first expedition in 1989. Furthermore, there have been many anecdotal stories of improved education and employment opportunities in social isolation after surgery. The organisation expanded in 2000 to introduce community ear assistants, who are specially trained in the diagnosis and treatment of ear disease and dispense hearing aids passed on from the NHS.